Marked weight loss on liraglutide 3.0 mg: Real-life experience of a Swiss cohort with obesity.
Sara SantiniNathalie VionnetJérôme PasquierElena Gonzalez RodriguezMontserrat FragaNelly PitteloudLucie FavrePublished in: Obesity (Silver Spring, Md.) (2022)
In a real-world setting, liraglutide 3.0 mg led to beneficial changes in WL and body composition, with a greater impact in women.
Keyphrases
- body composition
- weight loss
- bariatric surgery
- resistance training
- roux en y gastric bypass
- bone mineral density
- polycystic ovary syndrome
- gastric bypass
- insulin resistance
- weight gain
- pregnancy outcomes
- glycemic control
- high fat diet induced
- obese patients
- cervical cancer screening
- breast cancer risk
- physical activity
- postmenopausal women